1Steinhubl SR;Topol EJ.Risk reduction with long-term clopidogrel following percutaneous coronary intervention[J],2004(23).
2Moser LR;Kalus JS.Role of low-molecular-weight heparin in invasive management of non-ST-elevation acute coronary syndromes[J],2004(12).
3Wong GC;Giugliano RP;Antman EM.Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention[J],2003.
4Ferrari E;Benhamou M;Cerboni P.Coronary syndromes following aspirin withdrawal A special risk for late stent thrombosis,2005(03).
5Steinhubl SR;Berger PD;Mann JT Ⅲ.For the CREDO Investigators.Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention:A randomized controlled trial[J],2002(19).
6Fox KA;Mehta SR;Peters R.Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome:the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial[J],2004(10).
7Mehta SR;Yusuf S;Peters RJ.Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention:the PCI-CURE study[J]The Lancet,2001(9281):527-533.
8Lepantalo A;Virtanen KS;Heikkila J.LiMIted early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions[J],2004(06).
9Chen WH;Lee PY;Ng W.Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment[J],2004(43).
10Njaman W;Miyauchi K;Kasai T.Impact of Aspirin Treatment on Long-Term Outcome (Over 10Years) After Percutaneous Coronary Intervention[J],2006(01).
3Dawkins K D,Gershliek T,de Belder M,et al.Perculaneous coronary intervention:r～oannendations for good practice and training.Heart,2005,91(6):11.
4Silber S,Albe assort P,Aviles F F,et al.Guidelines for perculaneous coronary interventions.The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.Eur Heart J,2oo5.26(8):804.
5Braunwald E.Application of current guidelines to the management of unstable angina and non -ST-elevation myocardial infarction.Circulation,2003,108(16):28.
6Wong G C,Giugliano R P,Antman E M.Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary interv ention.JAMA,2003,289:331.
7Farb A,Burke A P,Kolodgie FD,et al.Pahological mechanisms of fatal late cornary atent thrombosis in humans.Circulation.2003,108 (10):1701.
9Naming W,Mi yauchi K,Kasai T,et al.Impact of Aspirin Treatment on Long-Term Outcome (Over 10 Years) After Percutaneous Coronary Intervention.Int Heart J,2006,47(1):37.
10Popma J J,Berger P,Ohman E M,et al.Antithmmbotic therapy during perculan cous coronals'intervention:the Seventh ACCP Conference on Antithronlbotic and Thrombolytie Therapy.Chest,2004,126(3):576.
